Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) dropped 6.5% during trading on Friday . The company traded as low as $2.42 and last traded at $2.61. Approximately 337 shares were traded during mid-day trading, a decline of 84% from the average daily volume of 2,104 shares. The stock had previously closed at $2.79.
Mayne Pharma Group Price Performance
The firm has a 50-day moving average of $3.04 and a 200 day moving average of $2.91.
Mayne Pharma Group Company Profile
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division.
Further Reading
- Five stocks we like better than Mayne Pharma Group
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How to Read Stock Charts for Beginners
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What Are Dividends? Buy the Best Dividend Stocks
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
